Non-Neoplastic Colon Disorders Randolph K Peterson, MD Department of Laboratory Medicine and Pathology.

Slides:



Advertisements
Similar presentations
Managing Crohn’s Disease through Nutritional Intervention
Advertisements

PR BLEEDING BY HELEN BERMINGHAM. MESENTERIC BLOOD VESSELS Coeliac trunk T12 foregut left gastric common heptic splenic SMA L1 midgut inferiorpancreaticoduodenal.
Inflammatory Intestinal Diseases. Ulcerative Colitis Unknown etiology Mucosal inflammation and ulceration in the large intestine Always involves the rectum.
Inflammatory Bowel Disease Professor Ravi Kant MS, FRCS (Edin), FRCS (Glasg), FAMS, DNB, FACS, FICS Professor of Surgery.
Lower GI Tract - Part One NFSC Clinical Nutrition McCafferty.
Inflammatory bowel disease/ Irritable bowel syndrome Dr. Syed Md. Basheeruddin Asdaq.
Ischemic Colitis Ri 陳宏彰.
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Crohn’s disease - A Review of Symptoms and Treatment
Ulcerative Colitis. Which of the following would not be associated with UC Toxic megacolon Granulomas Pseudopolyps Primary sclerosing cholangitis.
UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.
Inflammatory Bowel Diseases Dr. Nematollah Ahangar Assistant Prof. of Pharmacology.
Case A 25-year-old woman A 4-m history of abdominal pain in the left lower quadrant and bloody diarrhea.
Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) Idiopathic IBD is comprised of CD+UC and is characterized by chronic bowel inflammation. Idiopathic IBD is comprised of.
Overview of the Digestive System
Ahmad Hormati Assistant Professor of Gastroenterology Qom University of Medical Sciences.
Anna Giles, Surgical Registrar POWH
Inflammatory Bowel Diseases and Drugs. Inflammatory Bowel Diseases Ulcerative Colitis Crohn’s Disease Diverticulitis Irritable Bowel Syndrome*
1 Lotronex ® Presentation to GI Advisory Committee June 27, 2000 Hugo E. Gallo-Torres MD, PHD Medical Team Leader DGICDP CDER, FDA.
Nursing Management: Lower Gastrointestinal Problems
Understanding Lower Bowel Disease
DISEASES OF THE SMALL & LARGE INTESTINES Developmental anomalies Developmental anomalies –Atresia, stenosis, Meckel ’ s diverticulum, malrotation –Hirschsprung.
Inflammatory Bowel Disease NPN 200 Medical Surgical I.
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
Dr. Angus Lee SET 1 General Surgery. Burrill Crohn, an American Gastroenterologist, with his 2 other colleagues first described “Terminal ileitis” in.
Inflammatory Bowel Disease
Drugs used in inflammatory bowel disease and biological and immune therapy of IBD Prof. Hanan Hagar Pharmacology Department College of Medicine.
2012 Physicians Assistance WINTER CONFERENCE March 10, 2012.
Definitions UC Inflammation confined to mucosa Inflammation confined to mucosa Starting in rectum Starting in rectum May involve entire colon May involve.
Inflammatory bowel disease/ Irritable bowel syndrome Dr. Syed Md. Basheeruddin Asdaq.
Imaging of IBD and Other Colitides
Which of the following is/are true regarding Ulcerative Colitis (UC)? A. Females are affected more then males. B. Surgery is curative. C. The most consistent.
Inflammatory Bowel Disease (IBD)
Crohn Disease (Regional Enteritis)
It's Time A 63-year-old woman was admitted because of severe abdominal pain, fatigue and bloody diarrhea.
Small Bowel, SBO, IBD Outline Small bowel physiology SBO physiology
DIGESTIVE SYSTEM the gastrointestinal tract (GI tract), digestive tract, guts or gut is the system of organs within multicellular organisms that takes.
COLON DISEASE. POLYPOSIS Polyps are non malignant tumors on legs that grow from mucosa. Classification By etiology: Innate Acquired By process’ spreading:
 Two chronic inflammatory disorders of unknown etiology are Crohn ’ s disease (CD) and ulcerative colitis (UC).  CD is a granulomatous disease that.
ULCERATIVE COLITIS. Ulcerative colitis is an idiopathic chronic inflammatory disease of the colon that follows a course of relapse and remission. In a.
Crohn’s Disease BY: Brent Movson, Allison Cobb, Alma Hernandez.
DISEASES OF SMALL INTESTINE. PLAN CROHN’S DISEASE (CD) Etiology and Etiology and Epidemiology of CROHN’S DISEASE Pathology of CROHN’S DISEASE Pathology.
Small & Large Intestine Oct SMALL/LARGE INTESTINE NORMAL: Anat., Vasc., Mucosa, Endocr., Immune, Neuromuscular. PATHOLOGY: – CONGENITAL – ENTEROCOLITIS:
 2 MAJOR GROUPS : 1. ULCERATIVE COLITIS – colon involved 2. CROHN’S DIDEASE – the hole GI tract EPIDEMIOLOGY  most common in whites than in blacks and.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Anatomy and Physiology & Pathophysiology
Inflammatory Bowel Disease Crohn’s Disease And Ulcerative Colitis.
I NFLAMMATORY B OWEL D ISEASE. There are two forms of idiopathic inflammatory bowel disease (IBD): (a) Ulcerative Colitis, a mucosal inflammatory condition.
Kim Eastman RN,MSN, CNS. INFLAMMATORY BOWEL DISEASE  OVERVIEW  IMMUNOLOGIC DISEASE THAT RESULTS IN INTESTINAL INFLAMMATION  ULCERATIVE COLITIS  CROHN’S.
SURGICAL CONDITIONS OF THE INTESTINES
Gastrointestinal Block Pathology lecture Dec, 2015 Dr. Maha Arafah Dr. Ahmed Al Humaidi Inflammatory bowel disease.
Inflammatory Bowel Disease
What do these people all have in common?
Inflammatory Bowel Disease (IBD)
CANCER OF THE COLON AND RECTUM
(I) IBD CROHN DISEASE (granulomatous colitis) ULCERATIVE COLITIS
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
Crohn´s disease Domina Petric, MD.
Care of Patients with Inflammatory Intestinal Disorders
Lecture 12 Gastrointestinal Disorders Inflammatory Bowel Disease
“Drugs used in IBD and biological and immune therapy of IBD ”
Ulcerative Colitis Definition
Inflammatory bowel disease and Ulcerative colitis
Introduction of Inflammatory bowel disease-Crohn’s disease
Gastrointestinal Nutrition Block Pathology lecture Nov, 2018
Presentation transcript:

Non-Neoplastic Colon Disorders Randolph K Peterson, MD Department of Laboratory Medicine and Pathology

Colon Disorders: Review The colon is retroperitoneal for most of it’s length. Vascular supply: – Superior mesenteric artery: cecum, right colon, transverse colon – Inferior mesenteric: descending colon, sigmoid colon, proximal rectum – Hemorrhoidal branches of internal iliac: distal rectum

Colon Disorders: Review (2) This vascular distribution produces “Watershed Areas,” at the points they meet: – Splenic Flexure – Rectum What this means is that during times of systemic ischemia/shock/hypovolemia/etc. these areas have a compromised vascular supply and may infarct!

Colon Disorders: Review (3) The colon has an intrinsic nervous supply: Auerbach’s plexus (within the muscularis), and Meissner’s plexus (submucosa).

Colon Disorders: Malformations Hirschsprung’s Disease – Failure of nueroblasts to migrate to the end of the bowel: the distal portion is aganglionic. – ALWAYS involves the rectum (90% restricted to rectum) and extends proximally to a varying degree. – 80 % are male; 10 % have Down Syndrome; 4 % risk in siblings of affected individuals. – Histo: no ganglion cells with patchy nerve hyperplasia in submucosa.

Colon Disorders: Malformations (2) – Lack of peristalsis forms a functional obstruction – The distal portion dilates; “Megacolon.” – Surgical correction is required % mortality rate due to electrolyte imbalances and infection. Diverticula: – Outpouchings of Mucosa through a weakened area of the muscularis – Symptomatic in only 20%

Colon Disorders: Malformations (3) – Symptoms: abdominal discomfort and pain are variable. If inflamed/infected may fibrose, or form an abscess/perf/fistula. Hemorrhoids – Variceal dilations of the anal and perianal venous plexus – 5 % of population affected. Unusual under 30 except for pregnant females. – Types: External: below anorectal line; inferior hemorrhoidal plexus Internal: above; superior

Colon Disorders: Malformations (4) Angiodysplasia – Dilation and increased tortuosity of the submucosal veins in the cecum and ascending colon. – Probably acquired. – May cause bleeding in elderly. Misc.: Malrotation Duplication Imperforate anus

Colon Disorders: Inflammation Necrotizing Enterocolitis – Acute necrotizing inflammation of the small and large intestine. – Affects INFANTS! Supossedly 10% of full term babies (????). Most common in premies. – Peaks at 2-3 days of life following initiation of oral feeding. – More common in formula fed babes. – Symptoms: Vary from mild tenderness to bleeding, perf., sepsis. – Most common in terminal Ilium, cecum, ascending colon.

Colon Disorders: Inflammation Inflammatory Bowel Disease Etiology: Unknown, Probably multifactorial ?Genetic? (Families = 10x risk  ) – NOD2 = product of candidate gene at IBD1 locus on chromosome 16 – used by immune system cells to detect bacterial products through activation of cytokines – Recently: IL23R mutation prevents cell from binding proinflammatory protein

INFLAMMATORY BOWEL DISEASE: ETIOLOGY (2) Infectious: – Virus: rota, EBV, CMV – Bacteria: Pseudomonas, M. Kansasii, Chlamydia, Yersinia Current concept: Disease is product of overly-aggressive immune response to commensal bacteria in genetically predisposed person

INFLAMMATORY BOWEL DISEASE: ETIOLOGY (3) Immunologic: – Antibodies + immune complexes (1°? 2°?) – Cell-mediated: tissue lymphs (2°?) Other: vasculitis

IBD: CROHN DISEASE Chronic enteritis with recurrent acute relapses Granulomatous inflammation Fibrosing Enteritis (any level) Idiopathic

CROHN DISEASE: PATHOLOGY Transmural inflammation –  wall thick, rigid, scarred –  granulomatous –  mucosal ulcers long, thin “Skip areas” common

CROHN DISEASE: LOCATION 40% ileum only 30% terminal ileum + colon 30% colon only

CROHN DISEASE: PATHOLOGY Transmural inflammation –  wall thick, rigid, scarred –  granulomatous –  mucosal ulcers long, thin “Skip areas” common

CROHN DISEASE: COMPLICATIONS Stenosis Fistulae (bowel, bladder, perineum) Protein-losing enteropathy Malabsorption Systemic: – arthritis, uveitis, gallstones –  cancer (local; distant) 3%

CROHN DISEASE: COMPLICATIONS Stenosis Fistulae (bowel, bladder, perineum) Protein-losing enteropathy Malabsorption Systemic: – arthritis, uveitis, gallstones –  cancer (local; distant) 3%

CROHN DISEASE: COMPLICATIONS Stenosis Fistulae (bowel, bladder, perineum) Protein-losing enteropathy Malabsorption Systemic: – arthritis, uveitis, gallstones –  cancer (local; distant) 3%

CROHN DISEASE: THERAPY (1) Reduce antigenic load: – anti-inflammatory agents: 5-aminosalicylates (mesalamine) sulfasalazine antibodies against tumor necrosis factor (infliximab)—but serious side effects (activation of latent tb, lymphoma) – total parenteral nutrition – surgical diversion

CROHN DISEASE: THERAPY (2) Immunosuppression: – Steroids (budesonide = local effect but minimal systemic: rapid liver metabolize) – Immunosuppressives — azathioprine, methotrexate, cyclosporine – T-cell apheresis – Anti-tumor necrosis factor alpha (TNF-  ) monoclonal antibody (cA2)—only for severe disease or fistulae. 60% improve. Other: fish oil diet; smoking 

Ulcerative Colitis Begins in rectum; progresses proximally Limited to mucosa and submucosa Nongranulomatous No skip areas ("backwash ileitis") Scarring mild Ulcers: crypt abscess, irregular pseudopolyps p-ANCA (peripheral-antineutrophile cytoplasmic antibody) + 75% - 80% (only 8% in Crohn's)

CrohnsUC SiteAll of GI, extra GIColon InflammationGranulomatousNon-granulomatous Skip areasPresentAbsent Wall DepthFull ThicknessMucosa Fistula formationYesNo ObstructionYesNo Cancer3%30% +

CUC: COMPLICATIONS Stenosis: none Fistulae: none Protein-losing enteropathy: few Malabsorption: rare Systemic: primary sclerosing cholangitis  obstructive jaundice Cancer:  (duration & degree): – 10 yrs <1%, 30 yrs 30% Toxic megacolon

CUC: COMPLICATIONS Stenosis: none Fistulae: none Protein-losing enteropathy: few Malabsorption: rare Systemic: as in Crohn disease, plus primary sclerosing cholangitis  obstructive jaundice Cancer:  (duration & degree): – 10 yrs <1%, 30 yrs 30% Toxic megacolon

CUC: THERAPY Medical: – Sulfasalazine – Antigen-processing inhibitor (chloroquine) – Steroids – I.V. cyclosporine (T lymphs  Surgical: colectomy with ileoanal anastomosis

Colon Disorders: Inflammation Non IBD Ischemic Colitis – Most common in elderly in distal colon and watershed areas. – Early: edema, hemorrhage – Late (Chronic): fibrosis, psuedomembranes, psudopolyps Infectious: – Acute self-limited Colitis Numerous organisms.

Colon Disorders: Inflammation Non IBD (2) – Pseudomembranous Colitis Caused by Clostridium difficile. A pseudomembrane of fibrin and inflammatory cells Most often involves the right colon TEST for toxin in lab – Other infections that may involve the colon: Amebic, TB, CMV, Cryptosporidiosis